Counteraction of the multifunctional restriction factor tetherin
The interferon-inducible restriction factor tetherin (also known as CD317, BST-2 or HM1.24) has emerged as a key component of the antiviral immune response. Initially, tetherin was shown to restrict replication of various enveloped viruses by inhibiting the release of budding virions from infected c...
Main Author: | Daniel eSauter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00163/full |
Similar Items
-
Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction
by: Stuart J. D. Neil, et al.
Published: (2011-05-01) -
The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin
by: Sebastian Giese, et al.
Published: (2020-04-01) -
Identification of residues in the BST-2 TM domain important for antagonism by HIV-1 Vpu using a gain-of-function approach
by: Takeshi eYoshida, et al.
Published: (2011-02-01) -
Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins
by: Peter W. Ramirez, et al.
Published: (2019-09-01) -
Structural basis for the antiviral activity of BST-2/tetherin and its viral antagonism
by: Juan F. eArias, et al.
Published: (2011-12-01)